Brusatol’s anticancer activity and its molecular mechanism: a research update
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Wenyi Xi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Translational Research Institute for Neurological Disorders of Wannan Medical College, Department of Neurosurgery, the First Affiliated Hospital …. Hauptthemen laut MEDLINE: Quassins, Apoptosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wannan Medical College, Anhui Excellent Scientific Research and Innovation Team.
Abstract (Originalsprache)
Objective
Brusatol (BT) is a quassinoid compound extracted from Brucea javanica that is a traditional Chinese herbal medicine. Brusatol possesses biological and medical activity, including antitumor, antileukemia, anti-inflammatory, antitrypanosomal, antimalarial, and antitobacco mosaic virus activity. To summarize and discuss the antitumor effects of BT and its mechanisms of actions, we compiled this review by combining the extensive relevant literature and our previous studies.
Methods
We searched and retrieved the papers that reported the pharmacological effects of BT and the mechanism of BT antitumor activity from PubMed until July 2023. Key findings Numerous studies have shown that BT is a unique nuclear factor erythroid 2-related factor 2 (Nrf2) inhibitor that acts on various signaling pathways and has good antitumor properties. Brusatol shows great potential in cancer therapy by inhibiting cell proliferation, blocking the cell cycle, promoting tumor cell differentiation, accelerating tumor cell apoptosis, inducing autophagy, suppressing angiogenesis, inhibiting tumor invasion and metastasis, and reversing multidrug resistance.
Conclusion
This review summarizes recent updates on the antitumor activity and molecular mechanisms of BT and provides references for future development and clinical translation of BT and its derivatives as antitumor drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Translational Research Institute for Neurological Disorders of Wannan Medical College, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College…
- The Institutes of Brain Science, Wannan Medical College, No. 22 Wenchang West Road, Higher Education Park, Wuhu 241002, Anhui, China.
ORCID-Profile: Shizhang Ling
Förderung
- Wannan Medical College
- Anhui Excellent Scientific Research and Innovation Team
Zitieren
APA
Xi, W., Zhao, C., Wu, Z., Ye, T., Zhao, R., Jiang, X., & Ling, S. (2024). Brusatol’s anticancer activity and its molecular mechanism: a research update. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae017
Vancouver
Xi W, Zhao C, Wu Z, Ye T, Zhao R, Jiang X, et al. Brusatol’s anticancer activity and its molecular mechanism: a research update. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae017
BibTeX
@article{Xi2024,
author = {Xi, Wenyi and Zhao, Chenhui and Wu, Zeyu and Ye, Tongtong and Zhao, Rui and Jiang, Xiaochun and Ling, Shizhang},
title = {Brusatol’s anticancer activity and its molecular mechanism: a research update},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae017}
}
EUVIMED